Walleye Trading’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Sell
84,400
-100
-0.1% -$410 ﹤0.01% 2884
2025
Q4
$399K Buy
+84,500
New +$376K ﹤0.01% 2973
2025
Q1
Sell
-11,800
Closed -$45K 4481
2024
Q4
$45K Hold
11,800
﹤0.01% 3814
2024
Q3
$84.6K Hold
11,800
﹤0.01% 3377
2024
Q2
$86.5K Hold
11,800
﹤0.01% 3422
2024
Q1
$118K Sell
11,800
-35,600
-75% -$312K ﹤0.01% 3696
2023
Q4
$332K Sell
47,400
-22,600
-32% -$150K ﹤0.01% 3411
2023
Q3
$556K Buy
70,000
+21,300
+44% +$134K ﹤0.01% 2867
2023
Q2
$270K Sell
48,700
-4,000
-8% -$21.9K ﹤0.01% 3237
2023
Q1
$300K Sell
52,700
-29,900
-36% -$198K ﹤0.01% 3216
2022
Q4
$577K Buy
82,600
+63,100
+324% +$649K ﹤0.01% 2688
2022
Q3
$174K Buy
+19,500
New +$225K ﹤0.01% 3780

Other funds holding MSOS

Walleye Trading's MSOS Position: Q1 2026 in Review

Walleye Trading reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 11% in Q1 2026, selling an estimated $62.2K and leaving 126,727 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #2652.

Walleye Trading first reported a position in MSOS in Q3 2022 and has held it in 10 quarters since. The position peaked at $670K in Q4 2025. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

  • Walleye Trading held 126,727 shares of AdvisorShares Pure US Cannabis ETF worth $450K as of Q1 2026.
  • Walleye Trading sold 15,178 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $62.2K.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2652 holding.
  • Walleye Trading first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2022 and has held it in 10 quarters since.
  • Walleye Trading's AdvisorShares Pure US Cannabis ETF position peaked at $670K in Q4 2025.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.